北美血气和电解质分析仪市场预测至 2031 年 - 区域分析 - 按产品（血气分析仪、电解质分析仪、组合分析仪等）和最终用户（医院和诊所、临床和诊断实验室、家庭护理等）划分

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Product (Blood Gas Analyzer, Electrolyte Analyzer, Combined Analyzer, and Others) and End User (Hospitals and Clinics, Clinical and Diagnostic Laboratories, Homecare, and Others)

No. of Pages: 72    |    Report Code: BMIRE00030925    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Blood Gas and Electrolyte Analyzer Market
Free Sample Buy Now
2023 年北美血气和电解质分析仪市场价值为 9.3697 亿美元，预计到 2031 年将达到 14.0502 亿美元；预计 2023 年至 2031 年的复合年增长率为 5.3%。

医院急诊室患者数量增加推动北美血气和电解质分析仪市场发展

糖尿病、癌症、心脏病和其他慢性病的患病率上升推动了对医院急诊室 (ER) 的需求。医院急诊室为需要立即关注和医疗干预的严重慢性病患者提供重要的医疗服务。这些服务很复杂，每个部分对于提供护理都至关重要。紧急医疗服务的主要目标是立即治疗内科、外科和产科问题。在急诊医院急诊室寻求护理的患者数量不断增加，对血气和电解质分析仪的需求产生了积极影响。根据世界卫生组织 (WHO) 的数据，全球每年约有 1.5 亿患者到医院急诊室就诊。根据美国疾病控制与预防中心 (CDC) 2023 年发布的数据，美国每年约有 1.398 亿人次急诊就诊。此外，2011 年至 2021 年间，加利福尼亚州的急诊就诊量增加了 7.4%。随着急诊科面临越来越大的压力，需要对危重患者进行快速准确的评估，及时获得血气值、电解质水平和酸碱平衡的诊断信息变得至关重要。血气和电解质分析仪可提供现场诊断数据，用于评估和管理呼吸窘迫、代谢异常或危重疾病患者。这些分析仪能够实时洞察患者的氧合状态、酸碱平衡和电解质水平，这对于指导复苏措施和优化紧急情况下的临床结果至关重要。

急诊科对血气和电解质分析仪的需求不断增长，推动了技术的进步，例如便携式和即时护理设备，这些设备可以在患者床边进行快速检测。这些紧凑型分析仪通过促进及时诊断和治疗启动，提高了工作流程效率并改善了患者预后。随着医院优先加强急救服务以满足不断增加的患者群体的需求，血气和电解质分析仪市场正在见证越来越多地采用针对紧急和重症护理环境量身定制的技术先进解决方案。

北美血气和电解质分析仪市场概览

北美血气和电解质分析仪市场已细分为美国、加拿大和墨西哥。2023 年，美国占据了北美血气和电解质分析仪市场的最大份额。增长的推动力是公众对心血管疾病的认识不断提高，以及越来越多的研究和合作探索血气和电解质分析仪市场的创新治疗应用。随着各种关键参与者的加入，北美血气和电解质分析仪测试套件市场预计将蓬勃发展。此外，在医疗保健业务中采用医疗器械来提高质量和降低成本，也促进了该地区血气和电解质分析仪市场的增长。

北美血气和电解质分析仪市场收入和预测到 2031 年（百万美元）

北美血气和电解质分析仪市场细分

北美血气和电解质分析仪市场分为产品、最终用户和国家。

根据产品，北美血气和电解质分析仪市场分为血气分析仪、电解质分析仪、组合分析仪和其他。组合分析仪部分在 2023 年占据了最大的市场份额。

按最终用户划分，北美血气和电解质分析仪市场分为医院和诊所、临床和诊断实验室、家庭护理等。临床和诊断实验室部门在 2023 年占据了最大的市场份额。

按国家/地区划分，北美血气和电解质分析仪市场分为美国、加拿大和墨西哥。2023 年，美国占据了北美血气和电解质分析仪市场份额的主导地位。

雅培实验室、Dalko Diagnostics Private Limited、Erba Diagnostics Mannheim GmbH、Hoffmann-La Roche Ltd、Medica Corporation、Nova Biomedical Corporation、西门子医疗股份公司、Werfen SA、Radiometer Medical ApS 和 Sensa Core Medical Instrumentation Pvt Ltd. 是北美血气和电解质分析仪市场的一些领先公司。

North America Blood Gas and Electrolyte Analyzer Strategic Insights

Strategic insights for North America Blood Gas and Electrolyte Analyzer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-blood-gas-and-electrolyte-analyzer-market-strategic-framework.webp
Get more information on this report

North America Blood Gas and Electrolyte Analyzer Report Scope

Report Attribute Details
Market size in 2023 US$ 936.97 Million
Market Size by 2031 US$ 1,405.02 Million
Global CAGR (2023 - 2031) 5.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品
  • 血气分析仪
  • 电解质分析仪
  • 联合分析仪
By 最终用户
  • 医院和诊所
  • 临床和诊断实验室
  • 家庭护理
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Abbott Laboratories.
  • Dalko Diagnostics Private Limited.
  • Erba Diagnostics Mannheim GmbH.
  • Hoffmann-La Roche Ltd.
  • Medica Corporation.
  • Nova Biomedical Corporation.
  • Siemens Healthineers AG.
  • Werfen SA.
  • Radiometer Medical ApS.
  • Sensa Core Medical Instrumentation Pvt Ltd.
    		•
    Get more information on this report

    North America Blood Gas and Electrolyte Analyzer Regional Insights

    The regional scope of North America Blood Gas and Electrolyte Analyzer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-blood-gas-and-electrolyte-analyzer-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - North America Blood Gas and Electrolyte Analyzer Market

    1. Abbott Laboratories.
    2. Dalko Diagnostics Private Limited.
    3. Erba Diagnostics Mannheim GmbH.
    4. Hoffmann-La Roche Ltd.
    5. Medica Corporation.
    6. Nova Biomedical Corporation.
    7. Siemens Healthineers AG.
    8. Werfen SA.
    9. Radiometer Medical ApS.
    10. Sensa Core Medical Instrumentation Pvt Ltd.
    Frequently Asked Questions
    How big is the North America Blood Gas and Electrolyte Analyzer Market?

    The North America Blood Gas and Electrolyte Analyzer Market is valued at US$ 936.97 Million in 2023, it is projected to reach US$ 1,405.02 Million by 2031.

    What is the CAGR for North America Blood Gas and Electrolyte Analyzer Market by (2023 - 2031)?

    As per our report North America Blood Gas and Electrolyte Analyzer Market, the market size is valued at US$ 936.97 Million in 2023, projecting it to reach US$ 1,405.02 Million by 2031. This translates to a CAGR of approximately 5.3% during the forecast period.

    What segments are covered in this report?

    The North America Blood Gas and Electrolyte Analyzer Market report typically cover these key segments-

  • 产品 (血气分析仪, 电解质分析仪, 联合分析仪)
  • 最终用户 (医院和诊所, 临床和诊断实验室, 家庭护理)

    • What is the historic period, base year, and forecast period taken for North America Blood Gas and Electrolyte Analyzer Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Blood Gas and Electrolyte Analyzer Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in North America Blood Gas and Electrolyte Analyzer Market?

    The North America Blood Gas and Electrolyte Analyzer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories.
  • Dalko Diagnostics Private Limited.
  • Erba Diagnostics Mannheim GmbH.
  • Hoffmann-La Roche Ltd.
  • Medica Corporation.
  • Nova Biomedical Corporation.
  • Siemens Healthineers AG.
  • Werfen SA.
  • Radiometer Medical ApS.
  • Sensa Core Medical Instrumentation Pvt Ltd.
    • Who should buy this report?

    The North America Blood Gas and Electrolyte Analyzer Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Blood Gas and Electrolyte Analyzer Market value chain can benefit from the information contained in a comprehensive market report.

    north-america-blood-gas-and-electrolyte-analyzer-market